Patents by Inventor John Blacker

John Blacker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210017556
    Abstract: A process for oxidising a substrate selected from hydroxymethylfurfural (HMF), diformylfuran (DFF), hydroxymethylfurancarboxylic acid (HMFCA) and formylfurancarboxylic acid (FFCA). Said process comprises mixing said substrate with catalase, one or more further enzymes and hydrogen peroxide to form a reaction mixture. Said one or more further enzymes have the ability to catalyse oxidation of said substrate. Said hydrogen peroxide is provided at a total molar ratio of at least about 0.1:1 hydrogen peroxide to substrate.
    Type: Application
    Filed: March 26, 2019
    Publication date: January 21, 2021
    Inventors: Paul MINES, Paul LAW, Andrew CARNELL, Shane MCKENNA, John BLACKER, Nikil KAPUR
  • Patent number: 8865924
    Abstract: The present invention relates to compounds and their use as ligands, in particular, in metal catalyst complexes. The ligands of the invention are capable of binding to a solid support. The invention includes the ligands in their own right and when bound to a support and the compounds may be used to prepare metal catalyst complexes.
    Type: Grant
    Filed: June 7, 2013
    Date of Patent: October 21, 2014
    Assignee: University of Leeds
    Inventors: John Blacker, Kevin Treacher, Thomas Screen
  • Publication number: 20130267725
    Abstract: The present invention relates to compounds and their use as ligands, in particular, in metal catalyst complexes. The ligands of the invention are capable of binding to a solid support. The invention includes the ligands in their own right and when bound to a support and the compounds may be used to prepare metal catalyst complexes.
    Type: Application
    Filed: June 7, 2013
    Publication date: October 10, 2013
    Applicant: UNIVERSITY OF LEEDS
    Inventors: John Blacker, Kevin Treacher, Thomas Screen
  • Patent number: 8501829
    Abstract: The present invention relates to compounds and their use as ligands, in particular in metal catalyst complexes. The ligands of the invention are capable of binding to a solid support. The invention includes the ligands in their own right and when bound to a support and the compounds may be used to prepare metal catalyst complexes.
    Type: Grant
    Filed: January 9, 2009
    Date of Patent: August 6, 2013
    Assignee: NPIL Pharmaceuticals (UK) Limited
    Inventors: John Blacker, Kevin Treacher, Thomas Screen
  • Publication number: 20100298457
    Abstract: The present invention relates to compounds and their use as ligands, in particular in metal catalyst complexes. The ligands of the invention are capable of binding to a solid support. The invention includes the ligands in their own right and when bound to a support and the compounds may be used to prepare metal catalyst complexes.
    Type: Application
    Filed: January 9, 2009
    Publication date: November 25, 2010
    Applicant: NPIL PHARMACEUTICALS (UK) LIMITED
    Inventors: John Blacker, Kevin Treacher, Thomas Green
  • Publication number: 20090069579
    Abstract: A process for preparing intermediate compounds useful in the preparation of statins. The process is particularly useful for the preparation of atorvastatin. The process involves the reduction of two ketone groups at the same time using either a chiral transition metal catalyst or an enzyme based system.
    Type: Application
    Filed: November 21, 2006
    Publication date: March 12, 2009
    Inventors: John Blacker, Robin Fieldhouse
  • Patent number: 7408082
    Abstract: The present invention relates to a novel process for obtaining (1S,4S)N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthaleneamine from a mixture of its isomers. The process involves isomerising the 1-position and the 4-position and effecting separation of the desired isomer by methods such as fractured crystallization. The process can be operated as a continuous process.
    Type: Grant
    Filed: August 9, 2007
    Date of Patent: August 5, 2008
    Assignee: NPIL Pharmaceuticals (UK) Limited
    Inventor: John Blacker
  • Patent number: 4925937
    Abstract: The present invention relates to a process for the photocleavage of nucleic acids which consists in bringing a nucleic acid into contact with a solution of a 2,7-diazapyrene derivative and in subjecting the resulting reaction mixture to irradiation with visible light.
    Type: Grant
    Filed: December 15, 1987
    Date of Patent: May 15, 1990
    Assignee: Compagnie Oris Industrie
    Inventors: Jean M. Lehn, Jaroslaw Jazwinski, John Blacker